Isosorbidmononitrat Ismn Retard Pro Al

Isosorbide Mononitrate, the active ingredient in Isosorbidmononitrat Ismn Retard Pro Al, is a nitrate presented as an oral tablet for oral use. It is used to treat angina pectoris by improving myocardial oxygen supply in adults with coronary artery disease.

GNH USA supplies Isosorbidmononitrat Ismn Retard Pro Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isosorbide Mononitrate belongs to the nitrate class and is indicated for conditions related to myocardial ischemia. - Chronic stable angina: reduces the frequency and severity of chest pain episodes. - Effort‑induced angina: improves exercise tolerance and delays onset of symptoms. - Angina prophylaxis: maintains coronary blood flow to prevent anginal attacks.

Isosorbide Mononitrate may cause a range of adverse reactions, some of which are common and others that are serious or rare.

Common Side Effects: - Headache: throbbing pain often occurring shortly after dosing. - Dizziness: sensation of light‑headedness, especially when standing quickly. - Flushing: warm, reddened skin, typically on the face or neck. - Nausea: mild to moderate upset stomach. - Palpitations: awareness of heartbeat irregularities.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Syncope: sudden loss of consciousness. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Myocardial infarction: rare but possible worsening of heart ischemia. - Life‑threatening tachycardia: rapid heart rate that may need emergency care.

Before initiating therapy, clinicians should consider several safety measures. - Dose titration: start with a low dose and increase gradually to minimise hypotension. - Concomitant phosphodiesterase‑5 inhibitors: avoid due to risk of severe blood‑pressure fall. - Renal impairment: monitor renal function and adjust dose if necessary. - Hepatic impairment: use with caution, especially in severe liver disease. - Sudden discontinuation: taper gradually to prevent rebound angina. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Isosorbide Mononitrate can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause profound hypotension. - Other nitrates or nitric‑oxide donors: additive vasodilatory effect leading to dangerous blood‑pressure drops. - Antihypertensive agents (e.g., ACE inhibitors, beta‑blockers): can enhance hypotensive response.

Moderate Interactions (Monitor Closely): - Diuretics: may increase risk of electrolyte imbalance and low blood pressure. - Alcohol: can potentiate vasodilatory effects and dizziness.